Ivarest
NDC 10157-9077, Zinc Oxide, Benzyl Alcohol, and Diphenhydramine Hydrochloride, cream, from Blistex Inc.
- Product NDC
- 10157-9077
- Status
- Listed
- Labeler
- Blistex Inc
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10157-9077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZINC OXIDE14 g/100g
- BENZYL ALCOHOL10.5 g/100g
- DIPHENHYDRAMINE HYDROCHLORIDE2 g/100g
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Pediculicide [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10157-9077-1 | 10157907701 | 1 TUBE in 1 CARTON (10157-9077-1) / 56 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10157-9077 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10157-9077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10157-9077. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.